Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,474 | -7,904 | -29,491 | -22,003 | -15,217 |
| Depreciation Amortization | 243 | 88 | 381 | 296 | 208 |
| Accounts payable and accrued liabilities | 512 | 206 | -263 | 28 | -240 |
| Other Working Capital | 1,000 | -1,175 | -2,677 | -2,334 | -1,514 |
| Other Operating Activity | 3,023 | 1,599 | 4,693 | 2,831 | 2,068 |
| Operating Cash Flow | $-12,696 | $-7,186 | $-27,357 | $-21,182 | $-14,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -417 | -168 | -170 | -163 | -163 |
| Investing Cash Flow | $-417 | $-168 | $-170 | $-163 | $-163 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,007 | 450 | 35,602 | 1,253 | 1,232 |
| Financing Cash Flow | $5,007 | $450 | $35,602 | $1,253 | $1,232 |
| Beginning Cash Position | 39,673 | 39,673 | 31,598 | 31,598 | 31,598 |
| End Cash Position | 31,567 | 32,769 | 39,673 | 11,506 | 17,972 |
| Net Cash Flow | $-8,106 | $-6,904 | $8,075 | $-20,092 | $-13,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,696 | -7,186 | -27,357 | -21,182 | -14,695 |
| Capital Expenditure | -417 | -168 | -170 | -163 | -163 |
| Free Cash Flow | -13,113 | -7,354 | -27,527 | -21,345 | -14,858 |